A combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation, a new discovery suggests.
This type of anemia is the second-most common kind, and it can be an added burden for organ-transplant recipients and people with autoimmune disorders, as well as patients battling cancer or kidney disease and others. In addition to causing severe fatigue, the anemia can trigger headaches, dizziness, rapid heartbeat and sweating.
"Not only do these anemias cause unpleasant symptoms, but they are also associated with functional impairment and shorter lifespan," said the researcher. "Drawbacks of current therapies include their expense, tendency to lose of effectiveness and risk for serious side effects. This new therapeutic approach has potential to provide a low-cost, highly effective, safe alternative. A further benefit would be its easy applicability to resource-limited areas around the world."
People with anemia have fewer red blood cells and less hemogloblin than normal. Red blood cells carry oxygen throughout the body, while hemoglobin is an iron-rich protein in the red blood cells that transports oxygen molecules.
There are several types of anemias, but anemia of chronic disease and inflammation is triggered by restricted iron delivery to the bone marrow cells that make red blood cells.
The authors initially found that this inadequate availability of iron disrupts an important organelle inside our cells called the Golgi apparatus. This multi-layered organelle, which is shaped a bit like a ribbon candy, is responsible for packaging proteins and lipids (fats) vital to cells' healthy operations.
The researchers identified the underlying source of this problem as a breakdown of tiny microtubules, which provide critical scaffolding for Golgi assembly and for the intracellular transport machinery. Importantly, the researchers were able to pinpoint the trigger for this microtubule breakdown as the loss of a protein, ferritin, within the cell.
By knowing the root-cause of these cellular defects the scientists could tailor a targeted approach to reverse the problem in mouse models of anemia. Giving the lab mice a combination of two substances, isocitrate and fumarate, allowed ferritin recovery and microtubule regrowth, enabling long-term correction of anemia caused by inflammation.
This suggests that an inexpensive oral medication might one day help human patients, too. Pilot studies in patients with anemia associated with kidney disease are in the advanced planning phase.
https://newsroom.uvahealth.com/2021/04/26/anemia-discovery-points-to-more-effective-treatment-approaches/
https://www.nature.com/articles/s41467-021-21938-2
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Firon-control-of&filter=22
Break down of erythroid microtubule cytoskeleton in anemia
- 1,109 views
- Added
Edited
Latest News
Microfluidic systems resemb…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Uncovering the secret of lo…
By newseditor
Posted 10 May
A cubic-millimeter fragment…
By newseditor
Posted 10 May
mtDNA transcription Inhibit…
By newseditor
Posted 09 May
Other Top Stories
Molecular landscapes of human hippocampal immature neurons across l…
Read more
DNA recombinations are implicated in both development and disease
Read more
Molecular signatures of age-related macular degeneration
Read more
Key mechanism controlling skin regeneration
Read more
Hyaluronic acid awakens stem cells to repair damaged muscle
Read more
Protocols
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
A validation strategy to as…
By newseditor
Posted 04 May
Publications
Vascular network-inspired f…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Forward programming human p…
By newseditor
Posted 10 May
Cyclophilin A supports tran…
By newseditor
Posted 10 May
Sortases: structure, mechan…
By newseditor
Posted 10 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar